Lite Strategy, Inc. Operating Cash Flow
Lite Strategy, Inc. (LITS) reported Operating Cash Flow of -$7.96 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-13
- Lite Strategy, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.52M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.93M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.51M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$2.46M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$20.84M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$50.47M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$52.48M.
- Lite Strategy, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$48.75M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 130 month | Net Cash Provided by (Used in) Operating Activities 133 month | Net Cash Provided by (Used in) Operating Activities 136 month | Net Cash Provided by (Used in) Operating Activities 139 month | Net Cash Provided by (Used in) Operating Activities 142 month | Net Cash Provided by (Used in) Operating Activities 145 month | Net Cash Provided by (Used in) Operating Activities 148 month | Net Cash Provided by (Used in) Operating Activities 151 month | Net Cash Provided by (Used in) Operating Activities 154 month | Net Cash Provided by (Used in) Operating Activities 157 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$3.45M derived: sum of 2 quarters · filed 2026-05-13 | -$7.96M 10-Q · filed 2026-05-13 | -$10.42M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2025-12-31 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$6.44M 10-Q · filed 2026-02-17 | -$8.90M derived: sum of 3 quarters · filed 2026-02-17 | -$12.16M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2025-09-30 | -$4.51M 10-Q · filed 2025-11-14 | -$6.97M derived: sum of 2 quarters · filed 2025-11-14 | -$10.24M derived: sum of 3 quarters · filed 2026-05-13 | -$13.90M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2025-06-30 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | -$5.73M derived: sum of 2 quarters · filed 2026-05-13 | -$9.39M derived: sum of 3 quarters · filed 2026-05-13 | -$20.84M 10-K · filed 2025-09-26 | |||||||||||
| 2025-03-31 | -$3.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$6.93M derived: sum of 2 quarters · filed 2026-05-13 | -$18.38M 10-Q · filed 2026-05-13 | -$36.38M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2024-12-31 | -$3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$15.12M 10-Q · filed 2026-02-17 | -$33.12M derived: sum of 3 quarters · filed 2026-02-17 | -$36.04M derived: sum of 4 quarters · filed 2026-02-17 | |||||||||||
| 2024-09-30 | -$11.45M 10-Q · filed 2025-11-14 | -$29.45M derived: sum of 2 quarters · filed 2025-11-14 | -$32.38M derived: sum of 3 quarters · filed 2025-11-14 | -$43.43M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||
| 2024-06-30 | -$18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | -$20.93M derived: sum of 2 quarters · filed 2025-09-26 | -$31.98M derived: sum of 3 quarters · filed 2025-09-26 | -$50.47M 10-K · filed 2025-09-26 | |||||||||||
| 2024-03-31 | -$2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$13.98M derived: sum of 2 quarters · filed 2025-05-13 | -$32.47M 10-Q · filed 2025-05-13 | -$43.78M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||||
| 2023-12-31 | -$11.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | -$29.55M 10-Q · filed 2025-02-12 | -$40.85M derived: sum of 3 quarters · filed 2025-02-12 | -$52.98M derived: sum of 4 quarters · filed 2025-02-12 | |||||||||||
| 2023-09-30 | -$18.49M 10-Q · filed 2024-11-12 | -$29.79M derived: sum of 2 quarters · filed 2024-11-12 | -$41.92M derived: sum of 3 quarters · filed 2024-11-12 | -$56.19M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||
| 2023-06-30 | -$11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | -$23.43M derived: sum of 2 quarters · filed 2024-09-19 | -$37.70M derived: sum of 3 quarters · filed 2024-09-19 | -$52.48M 10-K · filed 2024-09-19 | |||||||||||
| 2023-03-31 | -$12.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-09 | -$26.40M derived: sum of 2 quarters · filed 2024-05-09 | -$41.18M 10-Q · filed 2024-05-09 | -$56.69M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||
| 2022-12-31 | -$14.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | -$29.05M 10-Q · filed 2024-02-13 | -$44.56M derived: sum of 3 quarters · filed 2024-02-13 | -$61.51M derived: sum of 4 quarters · filed 2024-02-13 | |||||||||||
| 2022-09-30 | -$14.78M 10-Q · filed 2023-11-09 | -$30.29M derived: sum of 2 quarters · filed 2023-11-09 | -$47.24M derived: sum of 3 quarters · filed 2023-11-09 | -$55.81M derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||
| 2022-06-30 | -$15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-26 | -$32.46M derived: sum of 2 quarters · filed 2023-09-26 | -$41.02M derived: sum of 3 quarters · filed 2023-09-26 | -$48.75M 10-K · filed 2023-09-26 | |||||||||||
| 2022-03-31 | -$16.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$25.52M derived: sum of 2 quarters · filed 2023-05-11 | -$33.24M 10-Q · filed 2023-05-11 | -$44.50M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||||
| 2021-12-31 | -$8.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-09 | -$16.29M 10-Q · filed 2023-02-09 | -$27.54M derived: sum of 3 quarters · filed 2023-02-09 | -$43.19M derived: sum of 4 quarters · filed 2023-02-09 | |||||||||||
| 2021-09-30 | -$7.72M 10-Q · filed 2022-11-14 | -$18.98M derived: sum of 2 quarters · filed 2022-11-14 | -$34.62M derived: sum of 3 quarters · filed 2022-11-14 | -$30.57M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||
| 2021-06-30 | -$11.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | -$26.90M derived: sum of 2 quarters · filed 2022-09-08 | -$22.85M derived: sum of 3 quarters · filed 2022-09-08 | -$31.96M 10-K · filed 2022-09-08 | |||||||||||
| 2021-03-31 | -$15.65M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-05-23 | -$11.60M derived: sum of 2 quarters · filed 2022-05-23 | -$20.71M 10-Q · filed 2022-05-23 | $48.41M derived: sum of 4 quarters · filed 2022-09-08 | |||||||||||
| 2020-12-31 | $4.05M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-05-23 | -$5.06M 10-Q/A · filed 2022-05-23 | $64.05M derived: sum of 3 quarters · filed 2022-09-08 | $53.76M derived: sum of 4 quarters · filed 2022-09-08 | |||||||||||
| 2020-09-30 | -$9.11M 10-Q/A · filed 2022-05-23 | $60.00M derived: sum of 2 quarters · filed 2022-09-08 | $49.71M derived: sum of 3 quarters · filed 2022-09-08 | $39.23M derived: sum of 4 quarters · filed 2022-09-08 | |||||||||||
| 2020-06-30 | $69.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | $58.82M derived: sum of 2 quarters · filed 2022-09-08 | $48.34M derived: sum of 3 quarters · filed 2022-09-08 | $34.26M 10-K · filed 2022-09-08 | |||||||||||
| 2020-03-31 | -$10.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | -$20.78M derived: sum of 2 quarters · filed 2021-05-06 | -$34.85M 10-Q · filed 2021-05-06 | -$42.92M derived: sum of 4 quarters · filed 2022-05-23 | |||||||||||
| 2019-12-31 | -$10.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | -$24.56M 10-Q · filed 2021-02-04 | -$32.62M derived: sum of 3 quarters · filed 2022-05-23 | -$43.97M derived: sum of 4 quarters · filed 2022-05-23 | |||||||||||
| 2019-09-30 | -$14.08M 10-Q · filed 2020-11-10 | -$22.14M derived: sum of 2 quarters · filed 2022-05-23 | -$33.48M derived: sum of 3 quarters · filed 2022-05-23 | -$30.68M derived: sum of 4 quarters · filed 2022-05-23 | |||||||||||
| 2019-06-30 | -$8.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-23 | -$19.41M derived: sum of 2 quarters · filed 2022-05-23 | -$16.61M derived: sum of 3 quarters · filed 2022-05-23 | -$29.42M 10-K/A · filed 2022-05-23 | |||||||||||
| 2019-03-31 | -$11.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | -$8.54M derived: sum of 2 quarters · filed 2020-05-07 | -$21.36M 10-Q · filed 2020-05-07 | -$24.84M derived: sum of 4 quarters · filed 2020-09-09 | |||||||||||
| 2018-12-31 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | -$10.02M 10-Q · filed 2020-02-06 | -$13.50M derived: sum of 3 quarters · filed 2020-09-09 | -$19.74M derived: sum of 4 quarters · filed 2020-09-09 | |||||||||||
| 2018-09-30 | -$12.82M 10-Q · filed 2019-11-07 | -$16.30M derived: sum of 2 quarters · filed 2020-09-09 | -$22.54M derived: sum of 3 quarters · filed 2020-09-09 | -$27.29M derived: sum of 4 quarters · filed 2020-09-09 | |||||||||||
| 2018-06-30 | -$3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | -$9.72M derived: sum of 2 quarters · filed 2020-09-09 | -$14.47M derived: sum of 3 quarters · filed 2020-09-09 | -$21.04M 10-K · filed 2020-09-09 | -$21.30M 10-K · filed 2018-08-30 | ||||||||||
| 2018-03-31 | -$6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | -$10.99M derived: sum of 2 quarters · filed 2019-05-09 | -$17.55M 10-Q · filed 2019-05-09 | ||||||||||||
| 2017-12-31 | -$4.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | -$11.31M 10-Q · filed 2019-02-07 | |||||||||||||
| 2017-09-30 | -$6.56M 10-Q · filed 2018-11-08 | ||||||||||||||
| 2017-06-30 | $3.49M 10-K · filed 2019-08-28 | ||||||||||||||
| 2016-06-30 | -$17.86M 10-K · filed 2018-08-30 | ||||||||||||||
| 2013-12-31 | -$4.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-11 | -$8.53M 10-Q · filed 2014-02-11 | -$11.30M derived: sum of 3 quarters · filed 2014-02-11 | -$13.93M derived: sum of 4 quarters · filed 2014-02-11 | -$99.51M 10-Q · filed 2014-02-11 | ||||||||||
| 2013-09-30 | -$4.06M 10-Q · filed 2013-11-08 | -$6.83M derived: sum of 2 quarters · filed 2013-11-08 | -$9.46M derived: sum of 3 quarters · filed 2013-11-08 | -$11.62M derived: sum of 4 quarters · filed 2014-02-11 | -$95.05M 10-Q · filed 2013-11-08 | ||||||||||
| 2013-06-30 | -$2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-18 | -$5.40M derived: sum of 2 quarters · filed 2013-09-18 | -$7.56M derived: sum of 3 quarters · filed 2014-02-11 | -$10.04M 10-K · filed 2013-09-18 | -$90.98M 10-K · filed 2013-09-18 | ||||||||||
| 2013-03-31 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | -$4.79M derived: sum of 2 quarters · filed 2014-02-11 | -$7.28M 10-Q · filed 2013-05-09 | -$8.58M derived: sum of 4 quarters · filed 2014-02-11 | -$88.22M 10-Q · filed 2013-05-09 | ||||||||||
| 2012-12-31 | -$2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-11 | -$4.65M 10-Q · filed 2014-02-11 | -$5.95M derived: sum of 3 quarters · filed 2014-02-11 | -$8.22M derived: sum of 4 quarters · filed 2014-02-11 | -$85.59M 10-Q · filed 2013-02-12 | ||||||||||
| 2012-09-30 | -$2.49M 10-Q · filed 2013-11-08 | -$3.79M derived: sum of 2 quarters · filed 2013-11-08 | -$6.06M derived: sum of 3 quarters · filed 2013-11-08 | -$7.84M derived: sum of 4 quarters · filed 2013-11-08 | -$83.43M 10-Q · filed 2012-11-13 | ||||||||||
| 2012-06-30 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-18 | -$3.58M derived: sum of 2 quarters · filed 2013-09-18 | -$5.35M derived: sum of 3 quarters · filed 2013-09-18 | -$7.08M 10-K · filed 2013-09-18 | -$80.94M 10-K · filed 2012-09-18 | ||||||||||
| 2012-03-31 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-09 | -$4.05M derived: sum of 2 quarters · filed 2013-05-09 | -$5.78M 10-Q · filed 2013-05-09 | -$7.41M derived: sum of 4 quarters · filed 2013-05-09 | -$79.64M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-12 | -$3.50M 10-Q · filed 2013-02-12 | -$5.14M derived: sum of 3 quarters · filed 2013-02-12 | -$6.85M derived: sum of 4 quarters · filed 2013-02-12 | -$77.36M 10-Q · filed 2012-02-09 | ||||||||||
| 2011-09-30 | -$1.73M 10-Q · filed 2012-11-13 | -$3.36M derived: sum of 2 quarters · filed 2012-11-13 | -$5.08M derived: sum of 3 quarters · filed 2012-11-13 | -$6.73M derived: sum of 4 quarters · filed 2012-11-13 | -$75.59M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | -$1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-18 | -$3.35M derived: sum of 2 quarters · filed 2012-09-18 | -$5.00M derived: sum of 3 quarters · filed 2012-09-18 | -$6.50M 10-K · filed 2012-09-18 | |||||||||||
| 2011-03-31 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | -$3.36M derived: sum of 2 quarters · filed 2012-05-15 | -$4.87M 10-Q · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | -$3.16M 10-Q · filed 2012-02-09 | |||||||||||||
| 2010-09-30 | -$1.50M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |